F L Hildebrand

981 total citations
9 papers, 788 citations indexed

About

F L Hildebrand is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F L Hildebrand has authored 9 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F L Hildebrand's work include Nitric Oxide and Endothelin Effects (8 papers), Heart Rate Variability and Autonomic Control (3 papers) and Pulmonary Hypertension Research and Treatments (2 papers). F L Hildebrand is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Heart Rate Variability and Autonomic Control (3 papers) and Pulmonary Hypertension Research and Treatments (2 papers). F L Hildebrand collaborates with scholars based in United States. F L Hildebrand's co-authors include John C. Burnett, Amir Lerman, Kenneth B. Margulies, Mark A. Perrella, L L Aarhus, Denise M. Heublein, A. Lerman, Evan Sandok, Brian O’Murchu and Thomas R. Schwab and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

F L Hildebrand

9 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F L Hildebrand United States 7 570 456 152 100 83 9 788
G Nomura Japan 15 237 0.4× 244 0.5× 99 0.7× 103 1.0× 88 1.1× 40 625
M REDFIELD United States 3 367 0.6× 428 0.9× 77 0.5× 98 1.0× 45 0.5× 3 599
H Vierhapper Austria 15 281 0.5× 300 0.7× 164 1.1× 248 2.5× 46 0.6× 61 900
Y Sugishita Japan 15 484 0.8× 696 1.5× 364 2.4× 199 2.0× 16 0.2× 50 1.2k
Frank Muders Germany 15 143 0.3× 748 1.6× 180 1.2× 136 1.4× 33 0.4× 34 988
Howard D. Weinberger United States 15 445 0.8× 503 1.1× 496 3.3× 298 3.0× 22 0.3× 27 1.1k
J.A. Avontuur Netherlands 12 215 0.4× 138 0.3× 136 0.9× 65 0.7× 56 0.7× 17 514
Tsuneo Ogawa Canada 14 180 0.3× 674 1.5× 150 1.0× 278 2.8× 41 0.5× 26 1.2k
E Hartter Austria 16 159 0.3× 447 1.0× 119 0.8× 159 1.6× 36 0.4× 34 901
Alan B. Silverberg United States 14 127 0.2× 205 0.4× 82 0.5× 120 1.2× 57 0.7× 23 837

Countries citing papers authored by F L Hildebrand

Since Specialization
Citations

This map shows the geographic impact of F L Hildebrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F L Hildebrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F L Hildebrand more than expected).

Fields of papers citing papers by F L Hildebrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F L Hildebrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F L Hildebrand. The network helps show where F L Hildebrand may publish in the future.

Co-authorship network of co-authors of F L Hildebrand

This figure shows the co-authorship network connecting the top 25 collaborators of F L Hildebrand. A scholar is included among the top collaborators of F L Hildebrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F L Hildebrand. F L Hildebrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lerman, A., Evan Sandok, F L Hildebrand, & John C. Burnett. (1992). Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction.. Circulation. 85(5). 1894–1898. 104 indexed citations
2.
Perrella, Mark A., F L Hildebrand, Kenneth B. Margulies, & John C. Burnett. (1991). Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 261(2). R323–R328. 56 indexed citations
3.
Hildebrand, F L, Mark A. Perrella, & John C. Burnett. (1991). The role of endothelium-derived relaxing factor in experimental congestive heart failure. Journal of the American College of Cardiology. 17(2). A281–A281. 5 indexed citations
4.
Margulies, Kenneth B., F L Hildebrand, Denise M. Heublein, & John C. Burnett. (1991). Radiocontrast increases plasma and urinary endothelin.. Journal of the American Society of Nephrology. 2(5). 1041–1045. 68 indexed citations
5.
Lerman, Amir, F L Hildebrand, L L Aarhus, & John C. Burnett. (1991). Endothelin has biological actions at pathophysiological concentrations.. Circulation. 83(5). 1808–1814. 163 indexed citations
6.
Hildebrand, F L & John C. Burnett. (1990). Endothelin at pathophysiologic concentrations is a potent renal vasoconstrictor resistant to atrial natriuretic factor. Journal of the American College of Cardiology. 15(2). A156–A156. 3 indexed citations
7.
Lerman, Amir, F L Hildebrand, Kenneth B. Margulies, et al.. (1990). Endothelin: A New Cardiovascular Regulatory Peptide. Mayo Clinic Proceedings. 65(11). 1441–1455. 108 indexed citations
8.
Margulies, Kenneth B., F L Hildebrand, Amir Lerman, Mark A. Perrella, & John C. Burnett. (1990). Increased endothelin in experimental heart failure.. Circulation. 82(6). 2226–2230. 233 indexed citations
9.
Hildebrand, F L, Edward C. Rosenow, Thomas M. Habermann, & Henry D. Tazelaar. (1990). Pulmonary Complications of Leukemia. CHEST Journal. 98(5). 1233–1239. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026